• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

麻醉与心脏电生理学。

Anaesthesia and cardiac electrophysiology.

作者信息

Atlee J L

出版信息

Eur J Anaesthesiol. 1985 Sep;2(3):215-56.

PMID:2866093
Abstract

Cardiac dysrhythmias occur in 60% or more of anaesthetized patients. While most are not immediately life-threatening, they are serious when 1) accompanied by atrioventricular (A-V) dyssynchrony and impaired myocardial performance, 2) a favourable myocardial oxygen balance is jeopardized, or 3) there is likelihood of progression to life-threatening dysrhythmias. Partial A-V dyssynchrony occurs with non-sinus origin supraventricular and A-V junctional rhythms, and complete A-V dyssynchrony with ventricular rhythms and advanced heart-block. Any tachydysrhythmia may increase the myocardial oxygen demand, and possibly reduce oxygen supply as well. Certain supraventricular tachydysrhythmias and most sustained ventricular rhythm disturbances are likely to predispose to life-threatening dysrhythmias. Thus, any cardiac rhythm disturbance should be of concern to the anaesthetist since it is a departure from normal and a sign of an untoward drug effect or altered physiological state. The purpose of this article is to summarize our current understanding of cardiac electrophysiological mechanisms, particularly how these apply to dysrhythmias that occur during anaesthesia, and to review the actions of, and indications for, antidysrhythmic drugs. A better understanding of electrophysiological mechanisms by anaesthetists should lead to improved patient management; hence, a reduced likelihood that dysrhythmias will occur that require specific drug or electrical management.

摘要

60%或更多的麻醉患者会发生心律失常。虽然大多数心律失常不会立即危及生命,但在以下情况下会很严重:1)伴有房室不同步和心肌功能受损;2)良好的心肌氧平衡受到威胁;3)有进展为危及生命的心律失常的可能性。部分房室不同步发生在非窦性起源的室上性和房室交界性节律中,而完全房室不同步则发生在室性节律和高度房室传导阻滞中。任何快速性心律失常都可能增加心肌需氧量,也可能减少氧供应。某些室上性快速性心律失常和大多数持续性室性节律紊乱可能易发展为危及生命的心律失常。因此,任何心律失常都应引起麻醉医生的关注,因为它偏离了正常状态,是药物不良反应或生理状态改变的迹象。本文的目的是总结我们目前对心脏电生理机制的理解,特别是这些机制如何应用于麻醉期间发生的心律失常,并回顾抗心律失常药物的作用和适应证。麻醉医生更好地理解电生理机制应能改善患者管理;因此,减少发生需要特定药物或电治疗的心律失常的可能性。

相似文献

1
Anaesthesia and cardiac electrophysiology.麻醉与心脏电生理学。
Eur J Anaesthesiol. 1985 Sep;2(3):215-56.
2
Basic cardiac electrophysiology and mechanisms of antiarrhythmic agents.心脏基本电生理学与抗心律失常药物的作用机制
Am J Hosp Pharm. 1986 Apr;43(4):957-74.
3
The development of new antidysrhythmic drugs.
Schweiz Med Wochenschr. 1973 Feb 24;103(8):262-71.
4
Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.抗心律失常药物。I. 作用机制与临床药理学。
Drugs. 1973;5(4):261-91. doi: 10.2165/00003495-197305040-00002.
5
Antiarrhythmic drugs: electrophysiological basis of their clinical usage.抗心律失常药物:其临床应用的电生理基础
Ann Thorac Surg. 1986 Jan;41(1):106-12. doi: 10.1016/s0003-4975(10)64510-9.
6
Pharmacotherapy of cardiac arrhythmias in acute myocardial infarction.急性心肌梗死中心律失常的药物治疗
Folia Med Neerl. 1971;14(5):225-36.
7
Antiarrhythmic drug therapy: new drugs and changing concepts.抗心律失常药物治疗:新药与观念转变
Fed Proc. 1986 Jul;45(8):2206-12.
8
Beta-blockers as antiarrhythmic agents.β受体阻滞剂作为抗心律失常药物。
Handb Exp Pharmacol. 2006(171):235-66.
9
[Anesthesia and cardiac electrophysiology (Part I)].[麻醉与心脏电生理学(第一部分)]
Rev Esp Anestesiol Reanim. 2005 May;52(5):276-89; quiz 289-90, 294.
10
Antiarrhythmic drugs.抗心律失常药物。
Clin Anesth. 1974;10(1):167-83.

引用本文的文献

1
Feasibility study evaluating arrhythmogenesis and cardiac damage after heart-base irradiation in mice: A brief communication.评估心脏底部照射后心律失常发生和心脏损伤的可行性研究:简要交流。
Vet Med Sci. 2020 Nov;6(4):1009-1016. doi: 10.1002/vms3.303. Epub 2020 Jun 10.
2
Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
Basic Res Cardiol. 1989 Jan-Feb;84(1):5-12. doi: 10.1007/BF01906998.